By Giulia Corso|2024-02-16T10:10:11+00:00February 16th, 2024|PODO/TERT256, telomerized cells|
Recent publication showcasing our PODO/TERT256 telomerized cell line February 16th, 2024, Vienna, Austria Our telomerized human podocyte cells (PODO/TERT256) were employed in an article
By Giulia Corso|2023-12-07T08:27:20+00:00December 7th, 2023|3Rs, cell line development, conferences, GCCP|
Evercyte contributing to reduce animal testing at key events December 7th, 2023, Vienna, Austria We participated as an invited attendee at
By Giulia Corso|2023-11-22T14:26:44+00:00November 22nd, 2023|cell line development, collaboration, EV cell factories, Extracellular Vesicles, mesenchymal stromal cells|
Evercyte Showcases Expertise in Japan’s Pharma Landscape November 22nd, 2023, Vienna, Austria We recently visited Summit Pharmaceuticals International to present our services
By Giulia Corso|2023-10-27T13:05:07+00:00October 27th, 2023|Extracellular vesicles and ageing, mesenchymal stromal cells|
We participated to the first MOVE symposium in Malaga, Spain October 27th, 2023, Vienna, AustriaWe participated to the first MOVE symposium held
By Giulia Corso|2023-12-01T09:15:19+00:00September 19th, 2023|Extracellular vesicles and ageing, mesenchymal stromal cells|
We participated to the Small New World 2.0 meeting in Graz, Austria September 12th, 2023, Vienna, Austria We participated to the
By Giulia Corso|2023-09-19T07:33:39+00:00August 4th, 2023|3Rs, collaboration, organ-on-a-chip, RPTEC/TERT1|
Collaboration with Nortis to establish human kidney-on-a-chip model August 4th, 2023. Vienna, Austria Our telomerized Human Renal Proximal Tubular Epithelial cells (RPTEC/TERT1) were used in collaboration with
By Giulia Corso|2023-07-11T09:18:04+00:00May 4th, 2023|EU funded project, Extracellular vesicles and ageing, mesenchymal stromal cells|
We are proud to announce our participation in the CHANGE project May 4th, 2023, Vienna, Austria The CHANGE project focuses on
By Giulia Corso|2023-04-05T11:15:37+00:00April 4th, 2023|Extracellular vesicles, mesenchymal stromal cells|
Recent publication showcasing our telomerized Wharton's jelly-MSCs as EV-cell factories April 4th, 2023, Vienna, AustriaOur telomerized Wharton's jelly-derived MSCs (WJ-MSC/TERT273)
By Giulia Corso|2022-11-30T10:09:00+00:00November 30th, 2022|Maternal and fetal health|
The LifeSaver project film November 30, 2022, Vienna, Austria Evercyte is a proud participant in the LifeSaver Project
